Chlamydia pneumoniae and atherosclerosis

被引：0
作者：
Hoymans, VY
Bosmans, JM
Ieven, M
Vrints, CJ
机构：
[1] Univ Antwerp, Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Univ Antwerp Hosp, Dept Microbiol, B-2650 Edegem, Belgium
来源：
ACTA CHIRURGICA BELGICA | 2002年 / 102卷 / 05期
关键词：
atherosclerosis; infection; Chlamydia pneumoniae;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Chlamydia pneumoniae, a human respiratory pathogen, has been linked to atherosclerotic disease based on sero-epidemiologic studies, direct detection of the organism in atherosclerotic lesions, animal experiments and tissue culture. In this review paper we propose to interprete results in line with the biology of Chlamydia with persistence of Chlamydia pneumoniae antigens in the pathogenesis of atherosclerosis rather than viable bacteriae.
引用
收藏
页码：317 / 322
页数：6
相关论文
共 40 条
[1]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[2]   Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens [J].
Apfalter, P ;
Blasi, F ;
Boman, J ;
Gaydos, CA ;
Kundi, M ;
Maass, M ;
Makristathis, A ;
Meijer, A ;
Nadrchal, R ;
Persson, K ;
Rotter, ML ;
Tong, CYW ;
Stanek, G ;
Hirschl, AM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) :519-524
[3]  
BLANCHARD TJ, 1997, PRINCIPLES PRACTICE, P723
[4]   Chlamydia pneumoniae IgG titres and coronary heart disease:: prospective study and meta-analysis [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Wong, YK ;
Bernardes-Silva, M ;
Ward, M .
BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :208-212
[5]   Standardizing Chlamydia pneumoniae assays:: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) [J].
Dowell, SF ;
Peeling, RW ;
Boman, J ;
Carlone, GM ;
Fields, BS ;
Guarner, J ;
Hammerschlag, MR ;
Jackson, LA ;
Kuo, CC ;
Maass, M ;
Messmer, TO ;
Talkington, DF ;
Tondella, ML ;
Zaki, SR ;
Bandea, C ;
Black, C ;
O'Conner, S ;
Papp, J ;
Perilla, MJ ;
Schuchat, A ;
Stevens, V ;
Van Beneden, CA ;
Zell, ER ;
Cohen, C ;
Campbell, LA ;
Wwang, SP ;
Grayston, JT ;
Deal, CD ;
Gaydos, C ;
Schindler, L ;
Taylor, CE ;
Mahony, J ;
Fong, IW ;
Leinonen, M ;
Saikku, P ;
Maas, M ;
Ossewaarde, JM ;
Persson, K ;
Boman, J ;
Apfalter, P .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :492-502
[6]   Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? [J].
Fong, IW ;
Chiu, B ;
Viira, E ;
Jang, D ;
Fong, MW ;
Peeling, R ;
Mahony, JB .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (06) :891-894
[7]  
Fryer RH, 1997, J INVEST MED, V45, P168
[8]   Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells [J].
Gaydos, CA ;
Summersgill, JT ;
Sahney, NN ;
Ramirez, JA ;
Quinn, TC .
INFECTION AND IMMUNITY, 1996, 64 (05) :1614-1620
[9]   The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies [J].
Glader, CA ;
Boman, J ;
Saikku, P ;
Stenlund, H ;
Weinehall, L ;
Hallmanns, G ;
Dahlén, GH .
EUROPEAN HEART JOURNAL, 2000, 21 (08) :639-646
[10]   Background and current knowledge of Chlamydia pneumoniae and atherosclerosis [J].
Grayston, JT .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S402-S410
1234